Dr. Kalra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 617-732-5500
Summary
- Sean Kalra, MD, is a pulmonologist specializing in critical care medicine based in Boston, MA. He completed medical school at the University of Colorado School of Medicine in 2017, followed by an internal medicine residency at Yale-New Haven Medical Center from 2017 to 2020. He then pursued a fellowship in pulmonary disease and critical care medicine at Brigham and Women's Hospital, from 2021 to 2024. Dr. Kalra is also advancing his education with an MPH in Quantitative Methods at Harvard TH Chan School of Public Health (2023-2025). His research work includes several publications in reputable journals such as the American Journal of Respiratory and Critical Care Medicine and Oncogene.
Education & Training
- Harvard TH Chan School of Public HealthMPH, Quantitative Methods, 2023 - 2025
- Brigham and Women's HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2021 - 2024
- Yale-New Haven Medical CenterResidency, Internal Medicine, 2017 - 2020
- University of Colorado School of Medicine Anschutz Medical CampusClass of 2017
Certifications & Licensure
- MA State Medical License 2021 - 2026
- CT State Medical License 2017 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- The Association of Interstitial Lung Abnormalities and Preserved Ratio Impaired Spirometry Findings With Mortality.Sean Kalra, Brian Hobbs, Gary M Hunninghake, Aravind A Menon, Rachel Putman
Chest. 2025-02-11 - 1 citationsDevelopment, Progression, and Mortality of Suspected Interstitial Lung Disease in COPDGene.Jonathan A Rose, Ann-Marcia C Tukpah, Claire Cutting, Noriaki Wada, Mizuki Nishino
American Journal of Respiratory and Critical Care Medicine. 2024-12-15 - Who Modifies the Modifiers: A High-Resolution View of the Genetic Modifiers of Cystic Fibrosis.Sean Kalra, Michael H Cho
American Journal of Respiratory and Critical Care Medicine. 2023-05-15
Journal Articles
- SMAD4 Loss promotes lung cancer formation but increases sensitivity to DNA topoisomerase inhibitorsSM Haeger, JJ Thompson, S Kalra, TG Cleaver, D Merrick, X-J Wang, SP Malkoski, Oncogene, 4/20/2015
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: